Construction of a recombinant plasmid harbouring the glyceraldenyde-3-phosphate dehydrogenase gene of periodic Brugia malayi and observation on DNA immunity.
dc.contributor.author | Fang, Z | |
dc.contributor.author | Tong, H | |
dc.contributor.author | Zhang, S | |
dc.contributor.author | Fang, H | |
dc.contributor.author | Lu, S | |
dc.contributor.author | Xu, B | |
dc.date.accessioned | 2012-12-18T07:49:27Z | |
dc.date.available | 2012-12-18T07:49:27Z | |
dc.date.issued | 2012-04 | |
dc.description.abstract | Purpose: Controlling and eliminating lymphatic filariasis will require further research of preventative measures and implementation. Parasite is dependent on glycolysis for ATP production. The glycolytic enzyme glyceraldenyde-3-phosphate dehydrogenase (GAPDH) plays an important role in glycolysis and therefore is either a potential target for anti-parasite drug development or a vaccine candidate. Therefore, we tried to investigate the DNA vaccine-elicited immune responses in BALB/c mice. Materials and Methods: We cloned a gene encoding the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) from periodic Brugia malayi into vector pcDNA3.1. Mice were injected at a dosage of 100 μg recombinant plasmid DNA with CpG intramuscular injection and immunized three times at 2-week intervals. pcDNA3.1 and normal saline were used as control. The tissue of muscles at the 4 weeks after the third injection was collected and target genes were detected using RT-PCR. The humoral responses elicited in mice by inoculation with the recombinant plasmid pcDNA3.1-BmGAPDH were detected using a standard ELISA. Two weeks after the third immunization, stimulation index (SI) was measured using the MTT method and the level of secreted IL-4 and INF-g were detected using ELISA. Results: Specific gene fragment coding GAPDH was amplified and the recombinant plasmid pcDNA3.1-BmGAPDH was constructed. Post-challenge sera from the mice immunized with the DNA vaccine had specific antibody titres of 1:1600 to 1:6400, and the highest titre was observed in the mice that were inoculated by pcDNA3.1-BmGAPDH/CpG at 6 weeks. At 4 weeks after immunization, the spleens of the mice were obviously enlarged. The proliferation of spleen T lymphocytes seen on the MTT assay was higher in the pcDNA3.1-BmGAPDH group than in the control group (P value <0.05). The levels of IL-4 and INF-g in serums from the immunized mice were significantly higher than that of the control (P value <0.05). Conclusions: We conclude that the recombinant eukaryotic plasmid pcDNA3.1-BmGAPDH could elicit humoral and cellular immune responses in mice. | en_US |
dc.identifier.citation | Fang Z, Tong H, Zhang S, Fang H, Lu S, Xu B. Construction of a recombinant plasmid harbouring the glyceraldenyde-3-phosphate dehydrogenase gene of periodic Brugia malayi and observation on DNA immunity. Indian Journal of Medical Microbiology. 2012 Apr-June; 30(2): 193-197. | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/143944 | |
dc.language.iso | en | en_US |
dc.source.uri | https://www.ijmm.org/article.asp?issn=0255-0857;year=2012;volume=30;issue=2;spage=193;epage=197;aulast=Fang | en_US |
dc.subject | DNA vaccine | en_US |
dc.subject | glyceraldenyde-3-phosphate dehydrogenase | en_US |
dc.subject | immune response | en_US |
dc.subject | mice | en_US |
dc.subject | periodic Brugia malayi | en_US |
dc.subject.mesh | Adjuvants, Immunologic --administration & dosage | |
dc.subject.mesh | Animals | |
dc.subject.mesh | Antibodies, Helminth --blood | |
dc.subject.mesh | Brugia malayi --enzymology | |
dc.subject.mesh | Brugia malayi --genetics | |
dc.subject.mesh | Brugia malayi --immunology | |
dc.subject.mesh | Cell Proliferation | |
dc.subject.mesh | Elephantiasis, Filarial --immunology | |
dc.subject.mesh | Elephantiasis, Filarial --prevention & control | |
dc.subject.mesh | Enzyme-Linked Immunosorbent Assay | |
dc.subject.mesh | Female | |
dc.subject.mesh | Glyceraldehyde-3-Phosphate Dehydrogenases --genetics | |
dc.subject.mesh | Glyceraldehyde-3-Phosphate Dehydrogenases --immunology | |
dc.subject.mesh | Injections, Intramuscular | |
dc.subject.mesh | Mice | |
dc.subject.mesh | Mice, Inbred BALB C | |
dc.subject.mesh | Oligodeoxyribonucleotides --administration & dosage | |
dc.subject.mesh | Plasmids --administration & dosage | |
dc.subject.mesh | Spleen --immunology | |
dc.subject.mesh | T-Lymphocytes --immunology | |
dc.subject.mesh | Vaccination --methods | |
dc.subject.mesh | Vaccines, DNA --administration & dosage | |
dc.subject.mesh | Vaccines, DNA --genetics | |
dc.subject.mesh | Vaccines, DNA --immunology | |
dc.subject.mesh | Vaccines, Synthetic --administration & dosage | |
dc.subject.mesh | Vaccines, Synthetic --genetics | |
dc.subject.mesh | Vaccines, Synthetic --immunology | |
dc.title | Construction of a recombinant plasmid harbouring the glyceraldenyde-3-phosphate dehydrogenase gene of periodic Brugia malayi and observation on DNA immunity. | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ijmm2012v30n2p193.pdf
- Size:
- 435.72 KB
- Format:
- Adobe Portable Document Format
- Description:
- Journal article
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: